Daniel Forton Selected Research

Daniel Forton Research Topics

5	Infections 11/2020 - 12/2012
3	COVID-19 02/2021 - 10/2020
3	Chronic Hepatitis C 01/2021 - 01/2006
3	Hepatitis C 11/2020 - 12/2012
2	Virus Diseases (Viral Diseases) 01/2023 - 01/2006
2	Fatigue 01/2019 - 11/2015
1	Leukemia 01/2023
1	Lymphoma (Lymphomas) 01/2023
1	Shock 10/2020
1	Inflammation (Inflammations) 01/2019
1	Chronic Fatigue Syndrome (Myalgic Encephalomyelitis) 01/2019
1	Stroke (Strokes) 11/2015
1	Insulin Resistance 11/2015
1	Fibrosis (Cirrhosis) 11/2015
1	Cryoglobulinemia 11/2015
1	Persistent Infection 12/2012
1	Chronic Hepatitis B 01/2006
1	Hepatitis 01/2006

5	Ribavirin (Virazole)FDA LinkGeneric 11/2015 - 01/2006
4	Interferon-alpha (Interferon Alfa)IBA 01/2019 - 01/2006
3	InterferonsIBA 11/2020 - 01/2006
2	CytokinesIBA 11/2020 - 01/2019
1	IsotopesIBA 01/2023
1	LigandsIBA 01/2023
1	tocilizumab (atlizumab)FDA Link 02/2021
1	Immunoglobulin G (IgG)IBA 01/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2020
1	Hydrocortisone (Cortisol)FDA LinkGeneric 10/2020
1	grazoprevirIBA 01/2020
1	sofosbuvir drug combination ledipasvirIBA 01/2020
1	elbasvirIBA 01/2020
1	Interleukin-10 (Interleukin 10)IBA 01/2019
1	Interferon alpha-2 (Roferon-A)FDA Link 01/2019
1	InterleukinsIBA 01/2019
1	KynurenineIBA 01/2019
1	SofosbuvirIBA 11/2015
1	Protease Inhibitors (Protease Inhibitor)IBA 06/2015
1	faldaprevirIBA 06/2015
1	Antiviral Agents (Antivirals)IBA 12/2012
1	Lamivudine (Epivir)FDA Link 01/2006
1	adefovir dipivoxil (Hepsera)FDA Link 01/2006

3	Therapeutics 01/2021 - 01/2006